Page 78 - பிரேசிலியன் ப்ரெஸிடெஂட் ஜெயர் போல்சனாரோ News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Jair Bolsonaro en quête de soutien au Parlement
laliberte.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from laliberte.ch Daily Mail and Mail on Sunday newspapers.
IMF forecasts stronger rebound for Latin American economies
lmtonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lmtonline.com Daily Mail and Mail on Sunday newspapers.
IMF forecasts stronger rebound for Latin American economies
thetelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thetelegraph.com Daily Mail and Mail on Sunday newspapers.
Brasilianer verlangen mehr Impfungen dw.com
Das Corona-Krisenmanagement des brasilianischen Präsidenten Jair Bolsonaro stößt zunehmend auf Kritik: Demonstranten würden den Impfskeptiker am liebsten aus dem Amt jagen. © Ricardo Moraes/REUTERS Ein Demonstrant in Rio fordert
In Brasilien sind erneut zehntausende Menschen gegen die Politik der Regierung des rechtsgerichteten Staatschefs Jair Bolsonaro auf die Straße gegangen. Bei Demonstrationen im ganzen Land forderten sie ein Amtsenthebungsverfahren gegen den Präsidenten, mehr Impfungen gegen das Coronavirus und wirtschaftliche Hilfen in der Pandemie. Auf Transparenten stand: Bolsonaro - korrupter Völkermörder. Amtsenthebung jetzt und Wir wollen Impfungen, er Schmiergeld. Weg mit Bolsonaro!
Representative image
HYDERABAD: After Bharat Biotech terminated its MoU with Brazilian partner Precisa Medicamentos on Friday, Brazil’s health regulator Anvisa (Agencia Nacional de Vigilancia Sanitaria) said it has suspended Covaxin’s clinical trials in Brazil. Precisa had submitted a request for randomised, double-blind and placebo-controlled phase-3 study of Covaxin in Brazil to Anvisa.
“The Coordination of Clinical Research determined this Friday the precautionary suspension of clinical studies of Covaxin in Brazil,” said a notice by Anvisa on website.
“The suspension was carried out as a result of a statement from the Indian company Bharat Biotech Limited International, sent to Anvisa on Friday (23/7). In the statement, Bharat informs that the company Necessidade Comercializacao de Medicamentos Ltda is no longer authorized to represent Bharat in Brazil, which in Anvisa’s assessment makes it impossible to carry out the study. Bharat is the manufacturer of the Cova